TrialLeukemia2021

Treatment-free remission following frontline nilotinib in patients with chronic phase chronic myeloid leukemia: 5-year update of the ENESTfreedom trial.

Jerald P Radich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.